2019年NICE《成人原发性高血压管理指南》解读

Interpretation of 2019 Hypertension:the Clinical Management of Primary Hypertension in Adults from the National Institute for Health and Care Excellence

高血压是脑卒中、心脏病、慢性肾衰竭等疾病的主要危险因素,高血压的及时治疗和综合管理具有重要意义。2019年8月英国国家卫生与临床优化研究所(NICE)发布了成人高血压诊断和管理指南,这是距2004年NICE高血压诊断和管理指南发布后的第3次更新,既沿用了以往的一些理念,又补充了许多新的内容,新版高血压管理指南在血压测量、高血压诊断、心血管风险、靶器官损害评估、降压治疗、血压监测及哪些患者需要专科医生诊治等方面均进行了全面而详细的阐述,尤其在高血压药物治疗的启动时机、治疗方案的选择及综合管理的治疗理念方面,值得临床医生借鉴与学习。

Hypertension is a major risk factor for stroke,heart disease,chronic renal failure and other diseases.The timely treatment and comprehensive management of hypertension is of great significance.In August 2019,the National Institute for Health and Care Excellence(NICE)of the United Kingdom issued the Guidelines for Hypertension in Adults:Diagnosis and Management,which was the third update since the 2004 NICE guidelines for the diagnosis and management of hypertension.It not only followed concepts of previous guidelines,but also added some new contents.The new edition of the guidelines for hypertension management provided a comprehensive and detailed description of blood pressure measurement,hypertension diagnosis,cardiovascular risk,target organ damage assessment,antihypertensive treatment,blood pressure monitoring and what kinds of patients require specialist diagnosis and treatment.In particular,the timing of starting drug treatment of hypertension,the choice of treatment options and the concept of comprehensive management are worthy of learning by clinicians.